Sectors
DTCP is set to exit video conferencing software developer BlueJeans Network which has agreed to an acquisition by Verizon Business reportedly sized at under $500m.
Wellness tracking app developer Biobeats has been bought after raising a total of $6.3m in funding from investors including Axa, Samsung and Cantora.
The aeests of Intel Capital and Fitbit-backed glucose monitor developer have been acquired by diabetes-focused peer One Drop.
SoftBank Vision Fund could hypothetically invest up to $200m if Zomato goes through with buying grocery delivery service Grofers in an all-share deal.
Maxburg Capital Partners paid an undisclosed amount for retail analytics provider Metoda, whose exiting investors included Tengelmann vehicle TEV.
Partners Healthcare and Medison Pharma-backed Keros Therapeutics floated at the top of its range and will look to advance its musculoskeletal disorder drug candidates.
Naver, Simon Property and O’Reilly Media-backed Foursquare is joining forces with peer Factual to create the world's biggest location intelligence provider.
Novo and Takeda are set to exit antibody therapy developer Symphogen in an acquisition by one of its strategic partners, Servier.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
